NO20032276L - Terapi for neurologiske, virale herpestilstander ved anvendelse av 1,4-dihydropyridin-kalsiumkanalblokkere - Google Patents
Terapi for neurologiske, virale herpestilstander ved anvendelse av 1,4-dihydropyridin-kalsiumkanalblokkereInfo
- Publication number
- NO20032276L NO20032276L NO20032276A NO20032276A NO20032276L NO 20032276 L NO20032276 L NO 20032276L NO 20032276 A NO20032276 A NO 20032276A NO 20032276 A NO20032276 A NO 20032276A NO 20032276 L NO20032276 L NO 20032276L
- Authority
- NO
- Norway
- Prior art keywords
- neurological
- therapy
- conditions
- calcium channel
- channel blockers
- Prior art date
Links
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 title 1
- OKLAEQBUDFSNDL-UHFFFAOYSA-N calcium;1,4-dihydropyridine Chemical compound [Ca].C1C=CNC=C1 OKLAEQBUDFSNDL-UHFFFAOYSA-N 0.000 title 1
- 229940127292 dihydropyridine calcium channel blocker Drugs 0.000 title 1
- 239000002866 dihydropyridine calcium channel blocker Substances 0.000 title 1
- 230000000926 neurological effect Effects 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 230000003612 virological effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2000/031994 WO2002041893A1 (en) | 2000-11-21 | 2000-11-21 | Therapy for herpes neurological viral conditions utilizing 1,4-dihydropyridine calcium channel blockers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20032276D0 NO20032276D0 (no) | 2003-05-20 |
| NO20032276L true NO20032276L (no) | 2003-06-30 |
Family
ID=21742018
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20032276A NO20032276L (no) | 2000-11-21 | 2003-05-20 | Terapi for neurologiske, virale herpestilstander ved anvendelse av 1,4-dihydropyridin-kalsiumkanalblokkere |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1343501A4 (de) |
| JP (1) | JP2004513965A (de) |
| CN (1) | CN1479616A (de) |
| AU (1) | AU2001224250A1 (de) |
| NO (1) | NO20032276L (de) |
| WO (1) | WO2002041893A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013526518A (ja) * | 2010-05-13 | 2013-06-24 | ザ ユニバーシティ オブ ケンタッキー リサーチ ファウンデーション | Ｍｃｉおよびアルツハイマー病の処置 |
| WO2020163815A1 (en) * | 2019-02-07 | 2020-08-13 | Innomed Technologies, Inc. | Ivig treatments for bell's palsy |
| CN109820852B (zh) * | 2019-03-11 | 2021-02-19 | 中国农业科学院兰州兽医研究所 | 一种尼莫地平在制备预防口蹄疫病毒感染的药物中的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4849412A (en) * | 1986-06-05 | 1989-07-18 | Board Of Regents, The University Of Texas System | Methods and compositions for treating viral infections |
| US5039678A (en) * | 1989-03-23 | 1991-08-13 | Wake Forest University | Method of increasing cranial vessel proliferation by administering nimodipine |
| SE9203857D0 (sv) * | 1992-12-22 | 1992-12-22 | Astra Ab | Use of an enantiomeric dihydropyridine |
| US5677308A (en) * | 1996-12-19 | 1997-10-14 | Lerner; A. Martin | Method for alleviating spasmodic torticollis |
-
2000
- 2000-11-21 EP EP00987986A patent/EP1343501A4/de not_active Withdrawn
- 2000-11-21 JP JP2002544071A patent/JP2004513965A/ja not_active Withdrawn
- 2000-11-21 CN CNA008201242A patent/CN1479616A/zh active Pending
- 2000-11-21 WO PCT/US2000/031994 patent/WO2002041893A1/en not_active Ceased
- 2000-11-21 AU AU2001224250A patent/AU2001224250A1/en not_active Abandoned
-
2003
- 2003-05-20 NO NO20032276A patent/NO20032276L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1479616A (zh) | 2004-03-03 |
| WO2002041893A1 (en) | 2002-05-30 |
| NO20032276D0 (no) | 2003-05-20 |
| EP1343501A1 (de) | 2003-09-17 |
| EP1343501A4 (de) | 2004-12-15 |
| AU2001224250A1 (en) | 2002-06-03 |
| JP2004513965A (ja) | 2004-05-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20004688D0 (no) | Terapi ved østrogenassosierte lidelser | |
| GB2394104B (en) | Pattern cross-matching | |
| GB0020336D0 (en) | Certificate validation mechanism | |
| GB0016681D0 (en) | Therapeutic compounds | |
| EG26726A (en) | Glycopeptide phosphate derivatives | |
| PT1360012T (pt) | Argila atapulgite purificada | |
| AU2002352744A8 (en) | Optically boosted router | |
| GB0113027D0 (en) | Safety headlights | |
| ATE362919T1 (de) | Lactamverbindungen | |
| DK1958938T3 (da) | Fremgangsmåde til fremstilling af 10,11-dihydro-10-oxo-5H-dibenz[b,f]azepin-5-carboxamid | |
| DE59812218D1 (de) | Laterales Kieferimplantat | |
| NO20032276D0 (no) | Terapi for neurologiske, virale herpestilstander ved anvendelse av 1,4-dihydropyridin-kalsiumkanalblokkere | |
| AU1603401A (en) | Pyranoindoles for treating glaucoma | |
| GB0101172D0 (en) | Optical routers | |
| NO20023164L (no) | Buekonstruksjon | |
| FR2810102B1 (fr) | Four a sole refractaire | |
| GB0013105D0 (en) | Therapeutic compounds | |
| GB0013490D0 (en) | Novel monsanto process | |
| IL149443A0 (en) | Compositions for treating viral diseases | |
| GB0011240D0 (en) | Novel phosphorous compounds | |
| GB0127855D0 (en) | Gutter gratings | |
| SG94758A1 (en) | Improved formwork | |
| TW522817U (en) | Improved structure for steamer | |
| GB9910852D0 (en) | Rap hii | |
| GB0002278D0 (en) | Novel phosphorus compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |